Q-Line Biotech plans to raise ₹214 crore through an IPO on NSE Emerge for working capital and loan repayment.

Q-Line Biotech plans to raise ₹214 crore through an IPO on NSE Emerge for working capital and loan repayment.

Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating in the in-vitro diagnostics and…